HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Farampator

HCID 4118151
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
211735-76-1
Standard SMILES
O=C(c1ccc2nonc2c1)N1CCCCC1
InChIKey
XFVRBYKKGGDPAJ-UHFFFAOYSA-N
Molecular formula
C12H13N3O2
Average molar mass
231.25 g/mol
Monoisotopic mass
231.10077667

Overview

Farampator is under investigation in clinical trial NCT00113022 (Org 24448 to Treat Major Depression).

Names & identifiers

Preferred name
Farampator
IUPAC
2,1,3-benzoxadiazol-5-yl(piperidin-1-yl)methanone
English name
FARAMPATOR
Molecular formula
C12H13N3O2
Molecular weight
231.25

Names & synonyms

Farampator211735-76-1CX-691CX691Org 24448Org-24448CX 6917X6P5N8K2LSCH-900460DTXSID90175413Piperidine, 1-(2,1,3-benzoxadiazol-5-ylcarbonyl)-farampatorum
Show more names
Org2444ORG2444Org24448, CX-691Farampator (CX691)Farampator, 10 mM in DMSOFarampator (CX-691, Org24448)
RefChem:9214655-(piperidine-1-carbonyl)-2,1,3-benzoxadiazoleDTXCID0097904Farampator-d10benzo[c][1,2,5]oxadiazol-5-yl(piperidin-1-yl)methanone2,1,3-benzoxadiazol-5-yl(piperidin-1-yl)methanone1-(2,1,3-Benzoxadiazol-5-ylcarbonyl)piperidineCX-691;Org24448

Database identifiers

CAS
211735-76-1
PubChem CID
4118151
DTXSID
DTXSID90175413
ChEMBL
CHEMBL1276138
UNII
7X6P5N8K2L
Nikkaji
J2.510.656C

Properties

Computed structural propertiesFilling in

XLogP
1.5
Topological polar surface area
59.2 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
1
Heavy atoms
17
Formal charge
0
Complexity
291

Physicochemical properties

Boiling point
398.3 · 398.3±34.0 °C(Predicted)
Density
1.299 · 1.299±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Sealed in dry,Store in freezer, under -20°C
solubility
30 mg/ml; · DMF: 30 mg/ml; DMF:PBS (pH7.2) (1:40): 25μg/ml; DMSO: 20 mg/ml
form
A crystalline solid
pka
-1.33 · -1.33±0.36(Predicted)
color
White to off-white
FDA UNII
7 X6P5N8K2L · 7X6P5N8K2L
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P264-P270-P271-P280-P301+P312-P330-P302+P352-P321-P304+P340-P305+P351+P338-P332+P313-P362+P364-P337+P313-P403+P233-P405-P501

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P264-P270-P271-P280-P301+P312-P330-P302+P352-P321-P304+P340-P305+P351+P338-P332+P313-P362+P364-P337+P313-P403+P233-P405-P501

Chemistry & industry

Applications · 1 item

UsesFarampator has shown effects as an AMPA receptor potentiator and glycine reuptake inhibitor with potential anti-psychotic efficacy and enhancement of prefrontal glutamatergic transmission. Farampator’s effects on both AMPA-PAMs and GlyT-1 inhibitor maybe also improve cognitive impairments in schizophrenia and in particular when combied with Risperidone (R525000).

Related reactions

4 records
New reaction record
HRID 427273 reaction equation
HRID 427273As product
HRID 427274 reaction equation
HRID 427274As product
HRID 1581511 reaction equation
HRID 1581511As product
HRID 1872660 reaction equation
HRID 1872660As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes